• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用临床直觉提高表型驱动优先级排序的准确性。

Leveraging clinical intuition to improve accuracy of phenotype-driven prioritization.

作者信息

Beckwith Martha A, Danis Daniel, Bridges Yasemin, Jacobsen Julius O B, Smedley Damian, Robinson Peter N

机构信息

The Jackson Laboratory for Genomic Medicine, Farmington, CT.

William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.

出版信息

Genet Med. 2025 Jan;27(1):101292. doi: 10.1016/j.gim.2024.101292. Epub 2024 Oct 10.

DOI:10.1016/j.gim.2024.101292
PMID:39396132
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11843448/
Abstract

PURPOSE

Clinical intuition is commonly incorporated into the differential diagnosis as an assessment of the likelihood of candidate diagnoses based either on the patient population being seen in a specific clinic or on the signs and symptoms of the initial presentation. Algorithms to support diagnostic sequencing in individuals with a suspected rare genetic disease do not yet incorporate intuition and instead assume that each Mendelian disease has an equal pretest probability.

METHODS

The LIkelihood Ratio Interpretation of Clinical AbnormaLities (LIRICAL) algorithm calculates the likelihood ratio of clinical manifestations represented by Human Phenotype Ontology terms to rank candidate diagnoses. The initial version of LIRICAL assumed an equal pretest probability for each disease in its calculation of the posttest probability (where the test is diagnostic exome or genome sequencing). We introduce Clinical Intuition for Likelihood Ratios (ClintLR), an extension of the LIRICAL algorithm that boosts the pretest probability of groups of related diseases deemed to be more likely.

RESULTS

The average rank of the correct diagnosis in simulations using ClintLR showed a statistically significant improvement over a range of adjustment factors.

CONCLUSION

ClintLR successfully encodes clinical intuition to improve ranking of rare diseases in diagnostic sequencing. ClintLR is freely available at https://github.com/TheJacksonLaboratory/ClintLR.

摘要

目的

临床直觉通常被纳入鉴别诊断,作为基于特定诊所所见患者群体或初始表现的体征和症状对候选诊断可能性的评估。用于支持疑似罕见遗传病个体诊断排序的算法尚未纳入直觉,而是假定每种孟德尔疾病具有相等的检验前概率。

方法

临床异常的似然比解释(LIRICAL)算法计算由人类表型本体术语表示的临床表现的似然比,以对候选诊断进行排序。LIRICAL的初始版本在计算检验后概率(其中检验为诊断性外显子组或基因组测序)时假定每种疾病具有相等的检验前概率。我们引入了似然比的临床直觉(ClintLR),这是LIRICAL算法的扩展,可提高被认为更有可能的相关疾病组的检验前概率。

结果

在一系列调整因素下,使用ClintLR进行模拟时正确诊断的平均排名显示出统计学上的显著改善。

结论

ClintLR成功编码临床直觉以改善诊断排序中罕见病的排名。ClintLR可在https://github.com/TheJacksonLaboratory/ClintLR上免费获取。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cfc/11843448/55641d0c6861/nihms-2053850-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cfc/11843448/9b0ea921527e/nihms-2053850-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cfc/11843448/86e245e432e1/nihms-2053850-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cfc/11843448/3169e1d3c20f/nihms-2053850-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cfc/11843448/55641d0c6861/nihms-2053850-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cfc/11843448/9b0ea921527e/nihms-2053850-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cfc/11843448/86e245e432e1/nihms-2053850-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cfc/11843448/3169e1d3c20f/nihms-2053850-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cfc/11843448/55641d0c6861/nihms-2053850-f0004.jpg

相似文献

1
Leveraging clinical intuition to improve accuracy of phenotype-driven prioritization.利用临床直觉提高表型驱动优先级排序的准确性。
Genet Med. 2025 Jan;27(1):101292. doi: 10.1016/j.gim.2024.101292. Epub 2024 Oct 10.
2
Interpretable Clinical Genomics with a Likelihood Ratio Paradigm.基于似然比范式的可解释临床基因组学
Am J Hum Genet. 2020 Sep 3;107(3):403-417. doi: 10.1016/j.ajhg.2020.06.021. Epub 2020 Aug 4.
3
CAVaLRi: An Algorithm for Rapid Identification of Diagnostic Germline Variation.CAVaLRi:一种快速识别诊断性种系变异的算法。
Hum Mutat. 2024 Apr 29;2024:6411444. doi: 10.1155/2024/6411444. eCollection 2024.
4
A clinical knowledge graph-based framework to prioritize candidate genes for facilitating diagnosis of Mendelian diseases and rare genetic conditions.一种基于临床知识图谱的框架,用于对候选基因进行优先级排序,以促进孟德尔疾病和罕见遗传病的诊断。
BMC Bioinformatics. 2025 Mar 14;26(1):82. doi: 10.1186/s12859-025-06096-2.
5
[Diagnostics in human genetics : Integration of phenotypic and genomic data].[人类遗传学诊断:表型与基因组数据的整合]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 May;60(5):542-549. doi: 10.1007/s00103-017-2538-5.
6
Diagnostic utility of transcriptome sequencing for rare Mendelian diseases.转录组测序对罕见孟德尔疾病的诊断效用。
Genet Med. 2020 Mar;22(3):490-499. doi: 10.1038/s41436-019-0672-1. Epub 2019 Oct 14.
7
Curation and expansion of the Human Phenotype Ontology for systemic autoinflammatory diseases improves phenotype-driven disease-matching.系统自身免疫性疾病的人类表型本体论的编纂和扩展提高了基于表型的疾病匹配。
Front Immunol. 2023 Sep 12;14:1215869. doi: 10.3389/fimmu.2023.1215869. eCollection 2023.
8
A robust phenotype-driven likelihood ratio analysis approach assisting interpretable clinical diagnosis of rare diseases.一种稳健的表型驱动似然比分析方法,辅助罕见病的可解释临床诊断。
J Biomed Inform. 2023 Jun;142:104372. doi: 10.1016/j.jbi.2023.104372. Epub 2023 Apr 25.
9
Phenotype-aware prioritisation of rare Mendelian disease variants.表型感知的罕见孟德尔疾病变异优先级排序。
Trends Genet. 2022 Dec;38(12):1271-1283. doi: 10.1016/j.tig.2022.07.002. Epub 2022 Aug 4.
10
Clinical utility in infants with suspected monogenic conditions through next-generation sequencing.通过下一代测序技术对疑似单基因疾病的婴儿进行临床评估。
Mol Genet Genomic Med. 2019 Jun;7(6):e684. doi: 10.1002/mgg3.684. Epub 2019 Apr 9.

引用本文的文献

1
Systematic benchmarking demonstrates large language models have not reached the diagnostic accuracy of traditional rare-disease decision support tools.系统基准测试表明,大语言模型尚未达到传统罕见病决策支持工具的诊断准确性。
medRxiv. 2024 Nov 7:2024.07.22.24310816. doi: 10.1101/2024.07.22.24310816.

本文引用的文献

1
A corpus of GA4GH phenopackets: Case-level phenotyping for genomic diagnostics and discovery.GA4GH 表型数据包语料库:用于基因组诊断和发现的病例级表型分析。
HGG Adv. 2025 Jan 9;6(1):100371. doi: 10.1016/j.xhgg.2024.100371. Epub 2024 Oct 10.
2
The Monarch Initiative in 2024: an analytic platform integrating phenotypes, genes and diseases across species.2024 年的“君主计划”:一个整合跨物种表型、基因和疾病的分析平台。
Nucleic Acids Res. 2024 Jan 5;52(D1):D938-D949. doi: 10.1093/nar/gkad1082.
3
The Human Phenotype Ontology in 2024: phenotypes around the world.
2024 年人类表型本体:世界各地的表型。
Nucleic Acids Res. 2024 Jan 5;52(D1):D1333-D1346. doi: 10.1093/nar/gkad1005.
4
A survey of algorithms for the detection of genomic structural variants from long-read sequencing data.长读测序数据中基因组结构变异检测算法研究综述。
Nat Methods. 2023 Aug;20(8):1143-1158. doi: 10.1038/s41592-023-01932-w. Epub 2023 Jun 29.
5
A robust phenotype-driven likelihood ratio analysis approach assisting interpretable clinical diagnosis of rare diseases.一种稳健的表型驱动似然比分析方法,辅助罕见病的可解释临床诊断。
J Biomed Inform. 2023 Jun;142:104372. doi: 10.1016/j.jbi.2023.104372. Epub 2023 Apr 25.
6
Clinical Validation and Diagnostic Utility of Optical Genome Mapping in Prenatal Diagnostic Testing.光学基因组图谱在产前诊断检测中的临床验证和诊断效用。
J Mol Diagn. 2023 Apr;25(4):234-246. doi: 10.1016/j.jmoldx.2023.01.006. Epub 2023 Feb 8.
7
Phenotype-aware prioritisation of rare Mendelian disease variants.表型感知的罕见孟德尔疾病变异优先级排序。
Trends Genet. 2022 Dec;38(12):1271-1283. doi: 10.1016/j.tig.2022.07.002. Epub 2022 Aug 4.
8
Recommendations for whole genome sequencing in diagnostics for rare diseases.罕见病诊断中全基因组测序的建议。
Eur J Hum Genet. 2022 Sep;30(9):1017-1021. doi: 10.1038/s41431-022-01113-x. Epub 2022 May 16.
9
Phenotype-driven approaches to enhance variant prioritization and diagnosis of rare disease.基于表型的方法提高罕见病变异的优先级和诊断。
Hum Mutat. 2022 Aug;43(8):1071-1081. doi: 10.1002/humu.24380. Epub 2022 Apr 27.
10
Clinical implementation of RNA sequencing for Mendelian disease diagnostics.RNA 测序在孟德尔疾病诊断中的临床应用。
Genome Med. 2022 Apr 5;14(1):38. doi: 10.1186/s13073-022-01019-9.